Pharmacies

Help patients get started on treatment

Photos not of actual patients

Have a patient
starting treatment?

Support Path is here to help.

Get your patients started today through the resources below, or call Support Path to connect live with a Program Navigator.

1-855-7-MYPATH (1-855-769-7284)

Resources to help patients access and start therapy

Co-pay coupon

Cost should not be a barrier to treatment. Register patients for a co-pay coupon

A co-pay coupon may help eligible patients reduce out-of-pocket costs of Gilead or Asegua treatment.

  • Eligible patients may pay as little as $5 per co-pay for their medicine. Patients are not eligible if they are enrolled in a government healthcare prescription drug program such as Medicaid or Medicare Part D (including patients who are in the Medicare coverage gap known as the “donut hole”)
  • If patients are eligible, the co-pay coupon program will cover the out-of-pocket costs for EPCLUSA, HARVONI, VOSEVI, SOVALDI, authorized generic of EPCLUSA, or authorized generic of HARVONI prescriptions up to a maximum of 25% of the catalog price of 3 bottles/packages of the applicable product

Click below to register and read full terms and conditions:

Co-pay coupon
EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg) tablets
HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets
VOSEVI® (sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100 mg) tablets
SOVALDI® (sofosbuvir 400 mg) tablets
Authorized Generic of EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg) tablets
Authorized Generic of HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets

Please see full Prescribing Information for EPCLUSA, HARVONI, VOSEVI, SOVALDI, sofosbuvir/velpatasvir, and ledipasvir/sofosbuvir, including BOXED WARNING.

Support Path Enrollment Form

Direct Patients to Submit a Support Path Enrollment Form

Support Path can help patients understand insurance coverage and financial support options to get started. Use the Support Path Enrollment Form to select from the following support options:

  • Benefits investigation
  • Prior Authorization and appeals information
  • Patient Assistance Program (PAP) eligibility screening
Please see full Prescribing Information for EPCLUSA, HARVONI, VOSEVI, SOVALDI, sofosbuvir/velpatasvir, and ledipasvir/sofosbuvir, including BOXED WARNING.
Gilead corporate logo Asegua logo

Photos not of actual patients.
EPCLUSA, the EPCLUSA logo, HARVONI, the HARVONI logo, SOVALDI, the SOVALDI logo, VOSEVI, the VOSEVI logo, SUPPORT PATH, the SUPPORT PATH logo, GILEAD and the GILEAD logo are trademarks of Gilead Sciences, Inc., or its related companies. ASEGUA and the ASEGUA logo are trademarks of Asegua Therapeutics LLC. All other trademarks referenced herein are the property of their respective owners.

©2021 Gilead Sciences, Inc. All rights reserved. PTFC0538 03/21